Advertisement
U.S. markets open in 4 hours 38 minutes

Nouveau Life Pharmaceuticals, Inc. (NOUV)

Other OTC - Other OTC Delayed Price. Currency in USD
0.00020.0000 (0.00%)
At close: 03:06PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0002
Open0.0002
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0001 - 0.0002
52 Week Range0.0001 - 0.0003
Volume33,919,840
Avg. Volume5,375,193
Market Cap969,597
Beta (5Y Monthly)-0.10
PE Ratio (TTM)N/A
EPS (TTM)-0.0000
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for NOUV

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • NOUVEAU LIFE PHARMACEUTICALS IN
    Analyst Report: Kinross Gold CorporationKinross Gold is a Canada-based gold producer, producing roughly 2.2 million gold equivalent ounces in 2023. The company had about a decade of gold reserves at the end of 2023. It operates mines in the Americas and West Africa after selling its low-cost Russian operations in 2022 in response to the invasion of Ukraine. The company has historically used acquisitions to fuel expansion into new regions and production growth. In 2022, Kinross purchased the Great Bear project in Canada, which, if developed, could produce an average of more than 500,000 ounces of gold per year for at least a decade.
    Rating
    Fair Value
    Economic Moat
    21 hours agoMorningstar
View more
  • We're sorry we weren't able to find anything about this topic.